BioLife Solutions Inc Capital Reinvestment Ratio

Latest as of June 2026: 0.03x

BioLife Solutions Inc capital reinvestment ratio. BioLife Solutions Inc (BLFS) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($6.35 Million) in capital expenditures ($167.00K). See free cash flow generation of BioLife Solutions Inc to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.03x
Capex / Operating Cash Flow

Operating Cash Flow

$6.35 Million
USD

Capital Expenditures

$167.00K
USD

Data as of

Jun 2026
Most recent filing

Capital Reinvestment Ratio of BioLife Solutions Inc (1998–2025)

Capital reinvestment ratio of BioLife Solutions Inc from 1998 to 2025. This chart tracks BioLife Solutions Inc's Capital Reinvestment Ratio across 10 annual periods. See BLFS financial flexibility index to measure the company's free cash flow as a share of total liabilities.

BioLife Solutions Inc Capital Reinvestment Ratio by Year (1998–2025)

BioLife Solutions Inc capital reinvestment ratio by year from 1998 to 2025. For the full cash flow conversion analysis, see BLFS cash flow metrics.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.98x $20.11 Million $19.70 Million ▲ +155.9%
2024 0.38x $8.43 Million $3.23 Million ▼ -46.2%
2020 0.71x $6.51 Million $4.63 Million ▲ +27.8%
2019 0.56x $1.21 Million $675.00K ▲ +161.3%
2018 0.21x $2.35 Million $500.00K ▼ -10.4%
2017 0.24x $605.00K $143.77K ▼ -85.3%
2013 1.62x $146.01K $236.67K ▲ +20.3%
2012 1.35x $854.93K $1.15 Million ▲ +954.6%
2004 0.13x $515.10K $65.80K ▼ -98.5%
1998 8.57x $29.12K $249.62K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow